THAAdmin Posted July 30, 2021 Report Share Posted July 30, 2021 Working in partnership with the Arkansas Racing Commission and the Arkansas HBPA, Oaklawn announced July 29 the prohibition of clenbuterol or any other beta2-adrenoceptor agonist within 120 days of a race, subject to regulatory approval. View the full article Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.